Skip to main content
. 2020 Jul 22;136(18):2027–2037. doi: 10.1182/blood.2020006449

Table 4.

AEI

Category of event Grade 1, n (%) Grade 2, n (%) Grade 3, n (%) Grade 4, n (%) Grade 5, n (%) All grade, n (%) EAIR (all severity grades), events per 100 person-months
Patients with ≥1 AEI* 7 (9.1) 30 (39.0) 25 (32.5) 9 (11.7) 4 (5.2) 75 (97.4)
Bleeding 40 (51.9) 5 (6.5) 3 (3.9) 0 0 48 (62.3) 4.49
 Major hemorrhage 0 0 3 (3.9) 0 0 3 (3.9) 0.13
Atrial fibrillation/ flutter 1 (1.3) 2 (2.6) 1 (1.3) 0 0 4 (5.2) 0.19
Hypertension 1 (1.3) 8 (10.4) 3 (3.9) 0 0 12 (15.6) 0.61
Second primary malignancies 3 (3.9) 6 (7.8) 7 (9.1) 2 (2.6) 1 (1.3) 19 (24.7) 0.98
 Skin cancers 2 (2.6) 7 (9.1) 4 (5.2) 0 0 13 (16.9) 0.66
Tumor lysis syndrome 0 0 0 0 0 0 0
Infections 4 (5.2) 45 (58.4) 17 (22.1) 1 (1.3) 3 (3.9) 70 (90.9) 11.48
 Hepatitis B reactivation* 1 (1.3) 0 0 0 0 1 (1.3)
Anemia 1 (1.3) 3 (3.9) 7 (9.1) 0 0 11 (14.3) 0.54
Neutropenia 0 2 (2.6) 6 (7.8) 6 (7.8) 0 14 (18.2) 0.73
Thrombocytopenia 3 (3.9) 2 (2.6) 1 (1.3) 0 0 6 (7.8) 0.28

AEI, AEs of interest.

*

EAIR not calculated.